David Mashaal

Senior Global Business Development Executive

Senior C-Suite Management Professional with broad, global and US experience in big pharma driving the startup, rapid growth, and profitability of multiple US and international ventures in the pharmaceutical and biotechnology industries. Skilled in fundraising, marketing-and-sales planning, direction, and participation, technology acquisition, manufacturing-facility operations, and administrative oversight. Resolute when negotiating, productive when selling, and undeterred when faced with a critical challenge.

Knowledge, Talent, and Dedication to Enrich Top and Bottom Lines

A dynamic, energetic leader and consistent proponent of the creative solution in combination with pragmatic restraint. Adept at cross-nation branding, structuring distributor associations that stretch the customer base, building and directing multi-cultural sales organizations, and maintaining operational efficiencies that lower costs and improve the customer experience. Depended upon and respected for providing lucrative direction in consequential situations.

 

Minneapolis, MN 55436
612-865-6295
dmash333@gmail.com

Global Team Leadership

Authentic and inspiring business-development executive with a practical approach to problem-solving and collaboration with key stakeholders. A passion for team and people development with unwavering integrity and a tenacious belief that people are an organization’s most important asset.

Maximizing Performance

Successful in defining and implementing innovative fit-for-purpose business plans, marketing strategies, and process improvements that maximize revenue growth, operational delivery, profitability, and overall financial performance.

Relationship Optimization

Strong international negotiation and relationship skills with team members, customers, executives, vendors, and cross-functional colleagues with associated years of trust and transparency that drive engagement, retention, output, and overall customer satisfaction.

Energetic Change Agent

High-level experience streamlining and managing operations and compliance in organizations to mitigate risk, drive better performance, and ensure unity of effort in improving organizational culture and results.

Multi-faceted Expert

Diversified in skills and knowledge. Maximize results by developing and executing profitable growth strategies with an extraordinary ability to institute best practices from multiple disciplines in new and unconventional ways.

Achievements

Work History

Licensing Deal Sheet
Download My Resume
2018 – Present

A Middle Eastern startup biotech manufacturing facility producing biosimilars, vaccines, and blood fractionation with a global portfolio potential value of $112 billion.
Senior Global Business Development Executive
Established the business’ international expansion strategy. Continue to assess global market capabilities for the product lines including vaccines, and biosimilars. Manage financial, business development, and marketing functions.

  • 112 billion in 13 branded biotech products obtained by researching availability of compatible additions on the global market and leading acquisition efforts.
  • $240 million raised in startup funds through presentations to government institutions, VIPs, and private investors.
  • $200 million in first-year sales projected, breakeven reached in the third year of operation, and a ten-year, projected $1.5 billion volume.
2015 – 2018

A century-old American pharmaceutical company supplying high-value, niche generics and branded drugs.
International Business Strategist
Accountable for assessing regulatory compliance, market potential, and profitability for each of 35 products. Wrote the global strategy, business and marketing plans, drove international sales, and directed product launches in multiple countries.

  • 50% boost in the efficiency of international operations produced by revising internal processes to conform with foreign-transaction norms, making changes to production software, helping acquire programming that accommodated overseas order coding, establishing partner-grade relationships with offshore distributors, and improving cross-departmental communications channels.
  • 20+% rise in international sales accomplished without registration by utilizing FDA approval, coordinating marketing efforts with a foreign distributor, and utilizing tendering as a marketing tool.
  • Increased product sales by 15% by increasing product listings and worked with wholesalers in the US.
2009 – 2015

Privately held biopharmaceutical company performing R&D in biosimilars and biobetters and marketing existing biopharmaceuticals and consumer-health products in the Asia-Pacific region.
Chief Executive Officer
In addition to general management of the firm, developed the business and marketing plans and guided operation of regulatory affairs, marketing and sales functions, and the finance department.

  • 12% hike in productivity and a corresponding 20% surge in sales and 10% in profitability attained by streamlining the corporate reporting structure to expand role responsibility, worker involvement, and job satisfaction.
  • Grew the company from startup to $10+ million in revenue by introducing multiple product lines into ten countries and ensured continued growth by installing managers in each added market.
  • Oversaw technology transfers in Europe, the Middle East, and the Asia-Pacific region.
2005 – 2009

High-growth biopharmaceutical company that develops, manufacturers, and markets recombinant, human-healthcare, biotechnology-derived products.
Vice President Global Corporate Business Development
Managed business activities in Asia Pacific, Europe, and the Americas market and appointed distributors in areas targeted for gains that resulted in a 30% increase in the company’s sales territory.

  • $5.7 billion in market potential contributed by acquiring two original biotechnologies.
  • Aided in the company’s listing on the Australian Stock Exchange.
  • Negotiated the purchase of an Indian biotech manufacturing company.
  • $700 million in Asian-market potential generated by negotiating acquisition of a new biosimilar with one of the world’s largest pharmaceutical companies.
  • $50 million in top-line delivered by piloting the creation of joint ventures, supply and distribution agreements, and technology transfers.
The parent of SciTech Group specializing in distribution of ethical, OTC, and medical products throughout Asia.
Chief Operating Officer – Asia Pacific | 2003 – 2005
Chief Operating Officer | 2001 – 2003
Director of Business Development | 1999 – 2001

Across the three positions, provided overall leadership for two divisions by establishing strategic expansion goals, developing operations, growing revenue and market share, and supervising administrative activities.

Education & Professional Development

Master of Business Administration in International Business & Marketing, Tulane University

Bachelor of Arts in Business Administration & Political Science, Whittier College

Legal Certification, Hamline University

Singapore Business Federation / American Association Singapore / Chinese Chamber of Commerce / Singapore American Club / American Chamber of Commerce, Member • Singapore Boy Scouts of America Cubmaster Pack 3017, Vice President, Treasurer, and Secretary • Boy Scouts of America-Singapore & Minnesota, Assistant Scout Master

Edina High School Orchestra Boosters, President

Contact Me

Minneapolis, MN 55436
612-865-6295
dmash333@gmail.com